Zobrazeno 1 - 10
of 41
pro vyhledávání: '"A. Gil Torralvo"'
Autor:
Domínguez-Cejudo, María A.1,2 (AUTHOR) mdcejudo-ibis@us.es, Gil-Torralvo, Ana1,2,3 (AUTHOR), Cejuela, Mónica3 (AUTHOR), Molina-Pinelo, Sonia1,2 (AUTHOR), Salvador Bofill, Javier1,2,3 (AUTHOR) mdcejudo-ibis@us.es
Publikováno v:
International Journal of Molecular Sciences. Dec2023, Vol. 24 Issue 23, p16771. 14p.
Autor:
Cejuela, Mónica1 (AUTHOR) monica.cejuela.sspa@juntadeandalucia.es, Gil-Torralvo, Ana1,2,3 (AUTHOR), Castilla, M. Ángeles2,3 (AUTHOR), Domínguez-Cejudo, M. Ángeles2,3 (AUTHOR), Falcón, Alejandro1 (AUTHOR), Benavent, Marta1,2,3 (AUTHOR), Molina-Pinelo, Sonia2,3 (AUTHOR), Ruiz-Borrego, Manuel1 (AUTHOR), Salvador Bofill, Javier1,2,3 (AUTHOR) monica.cejuela.sspa@juntadeandalucia.es
Publikováno v:
International Journal of Molecular Sciences. May2023, Vol. 24 Issue 10, p8488. 16p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maria A Dominguez-Cejudo, Raquel Chapresto, Ana Gil-Torralvo, Francisco Javier Salvador Bofill, Sonia Molina-Pinelo
Publikováno v:
Cancer Research. 83:P2-26
Introduction and objectives Estrogen receptor positive (ER+) tumors are the most common form of breast cancer and are responsible for most of the deaths from the disease. Treatment of ER+ breast cancer comprises interventions that suppress estrogen p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2d7566ac7ca40812b900cc8f1237fad
https://doi.org/10.1158/1538-7445.sabcs22-p2-26-17
https://doi.org/10.1158/1538-7445.sabcs22-p2-26-17
Autor:
Ana Gil-Torralvo, Marta Benavent, Maria A Dominguez-Cejudo, Alejandro Falcon, Mónica Cejuela, Begoña Vieites, Sonia Molina-Pinelo, Manuel Ruiz Borrego, Juan de la Haba-Rodríguez, Maria I Queipo, Francisco Javier Salvador Bofill
Publikováno v:
Cancer Research. 83:P1-04
INTRODUCTION Human Epidermal Growth Factor Receptor (HER2) is overexpressed and/or amplified in 15-20% of breast cancer at time of first diagnosis and is associated with an aggressive clinical progression disease. Management of HER2+ early breast can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c26e418901bd76ee953ac4b2b866f6a2
https://doi.org/10.1158/1538-7445.sabcs22-p1-04-18
https://doi.org/10.1158/1538-7445.sabcs22-p1-04-18
Autor:
Ana Gil-Torralvo, Marta Benavent, Maria A Dominguez-Cejudo, Alejandro Falcon, Begoña Vieites, Sonia Molina-Pinela, Manuel Ruiz, Álvaro Montaño, Rosario Gónzalez, Julia Martínez, Juan de la Haba, Antonio Rodríguez, Maria I Queipo, Begoña Jímenez, Javier Salvador-Bofill
Publikováno v:
Cancer Research. 82:P2-07
INTRODUCTION. In response to neoadjuvant therapy, pathological complete response (pCR; lack of residual disease in breast and lymph nodes), has been proposed as a prognostic marker for long-term clinical outcomes, such as disease-free (DFS) and overa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61e9aa3e06c36ec58618964b45fec331
https://doi.org/10.1158/1538-7445.sabcs21-p2-07-08
https://doi.org/10.1158/1538-7445.sabcs21-p2-07-08
Autor:
Zugazagoitia, J., Falcon Gonzalez, A., Navarro Mendivil, A.F., Sanchez Gastaldo, A., Simoes da Rocha, P.F., Cote, G.M., Bockorny, B., Molina Cerrillo, J., Artal, A., Baena Espinar, J., Gil Torralvo, A., Ponce Aix, S., Bote De Cabo, H., Martinez Perez, J., Martínez, S., López-Vilariño, J.A., Kahatt, C., Gómez, J., Paz-Ares, L.G.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S1064-S1065
Autor:
Gil Torralvo, A., Vieito, M., Martinez Perez, J., Pretelli, G., Martinez, V., Boggio, G.F., Fernandéz, C.M., Hernandez, A., Cristoveanu, E., Belgrano, A., Kahatt, C., Fudio, S., Nieto, A., Redondo, A.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S508-S508
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mónica Cejuela, Ana Gil-Torralvo, M. Ángeles Castilla, M. Ángeles Domínguez-Cejudo, Alejandro Falcón, Marta Benavent, Sonia Molina-Pinelo, Manuel Ruiz-Borrego, Javier Salvador Bofill
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 10; Pages: 8488
By the end of 2020, there were more than 8 million women alive who had received a breast cancer diagnosis in the previous 5 years, making it the most prevalent neoplasia in the world. About 70% of breast-cancer cases present positivity for estrogen a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49f2cee5a03fafd59e85c5fadb7f9e21
https://doi.org/10.3390/ijms24108488
https://doi.org/10.3390/ijms24108488